Get started
AstraZeneca Pharma India LimitedAstraZeneca Pharma India LimitedAstraZeneca Pharma India Limited

AstraZeneca Pharma India Limited

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsSeasonalsETFs
Full chart
Full chart

Compare with AstraZeneca Pharma India Limited



Key stats


Market capitalization
‪150.76 B‬ INR
Dividend yield (indicated)
0.60%
Price to earnings Ratio (TTM)
88.90
Basic EPS (TTM)
67.85 INR
Net income (FY)
‪1.88 B‬ INR
Revenue (FY)
‪22.76 B‬ INR
Shares float
‪4.60 M‬
Beta (1Y)
0.71

Employees


Employees (FY)
760
Change (1Y)
−42−5.24%
Revenue / Employee (1Y)
‪29.94 M‬ INR
Net income / Employee (1Y)
‪2.47 M‬ INR

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Praveen Rao Akkinepally
Website
astrazeneca.in
Headquarters
Bangalore
Founded
1979
IPO date
Jul 30, 1998
ISIN
INE203A01020
FIGI
BBG000CNNKY8
Identifiers
ISIN INE203A01020
CFI code
ESVUFN
AstraZeneca Pharma India Ltd. is engaged in the manufacturing, distribution, and marketing of pharmaceutical products and clinical trial services. It focuses in the areas of cardiovascular and metabolic disease, cancer and respiratory, inflammatory, and autoimmune disease. The company was founded on July 11, 1979 and is headquartered in Bangalore, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


SPEM
State Street SPDR Portfolio Emerging Markets ETF
Weight0.03%
Market value‪5.96 M‬
SMIN
Ishares MSCI India Small Cap ETF
Weight0.08%
Market value‪563.05 K‬
GMF
State Street SPDR S&P Emerging Asia Pacific ETF
Weight0.07%
Market value‪283.28 K‬
DGS
WisdomTree Emerging Market SmallCap Fund
Weight0.00%
Market value‪48.48 K‬
MOHEALTH
Motilal Oswal S&P BSE Healthcare ETF
Weight0.27%
Market value‪12.51 K‬
DGSE
WisdomTree Emerging Markets SmallCap Dividend UCITS ETF
Weight0.01%
Market value‪3.01 K‬

Explore more ETFs 

Frequently asked questions


The current price of ASTRAZEN is 5,913.00 INR — it has decreased by −1.95% in the past 24 hours. Watch AstraZeneca Pharma India Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange AstraZeneca Pharma India Limited stocks are traded under the ticker ASTRAZEN.
ASTRAZEN stock has fallen by −8.90% compared to the previous week, the month change is a −14.80% fall, over the last year AstraZeneca Pharma India Limited has showed a −36.14% decrease.
ASTRAZEN reached its all-time high on Jun 13, 2025 with the price of 10,653.05 INR, and its all-time low was 114.60 INR and was reached on Oct 29, 2003. View more price dynamics on ASTRAZEN chart.
See other stocks reaching their highest and lowest prices.
ASTRAZEN stock is 3.37% volatile and has beta coefficient of 0.71. Track AstraZeneca Pharma India Limited stock price on the chart and check out the list of the most volatile stocks — is AstraZeneca Pharma India Limited there?
Today AstraZeneca Pharma India Limited has the market capitalization of ‪150.76 B‬, it has decreased by −6.33% over the last week.
Yes, you can track AstraZeneca Pharma India Limited financials in yearly and quarterly reports right on TradingView.
ASTRAZEN net income for the last quarter is ‪379.30 M‬ INR, while the quarter before that showed ‪448.80 M‬ INR of net income which accounts for 0.00% change. Track more AstraZeneca Pharma India Limited financial stats to get the full picture.
AstraZeneca Pharma India Limited dividend yield was 0.46% in 2025, and payout ratio reached 47.99%. The year before the numbers were 0.37% and 69.12% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 6, 2026, the company has 760 employees. See our rating of the largest employees — is AstraZeneca Pharma India Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AstraZeneca Pharma India Limited EBITDA is ‪2.58 B‬ INR, and current EBITDA margin is 11.68%. See more stats in AstraZeneca Pharma India Limited financial statements.
Like other stocks, ASTRAZEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AstraZeneca Pharma India Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AstraZeneca Pharma India Limited technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AstraZeneca Pharma India Limited stock shows the sell signal. See more of AstraZeneca Pharma India Limited technicals for a more comprehensive analysis.